Lonza Group traded at 548.20 this Wednesday July 6th, increasing 18.60 or 3.51 percent since the previous trading session. Looking back, over the last four weeks, Lonza Group gained 3.72 percent. Over the last 12 months, its price fell by 19.29 percent. Looking ahead, we forecast Lonza Group to be priced at 505.80 by the end of this quarter and at 467.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
548.20
Daily Change
3.51%
Yearly
-19.29%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 31.00 0.21 0.68% -43.29%
Akzo Nobel 61.20 -0.18 -0.29% -41.71%
Alcon AG 69.04 1.20 1.77% 4.51%
Almirall SA 10.61 -0.26 -2.39% -29.55%
AstraZeneca 10,978.00 178.00 1.65% 26.80%
BASF 39.75 0.43 1.08% -40.14%
Bayer 56.19 0.67 1.21% 10.24%
Beiersdorf 100.70 1.94 1.96% -3.73%
DSM 141.90 1.80 1.28% -12.54%
Fresenius Medical Care 47.47 0.21 0.44% -31.00%
Fresenius 28.74 0.21 0.74% -34.97%
Geberit 477.10 11.70 2.51% -32.88%
Genmab 2,415.00 8.00 0.33% -9.82%
Givaudan 3,484.00 22.00 0.64% -20.76%
GN Store Nord 242.10 -3.00 -1.22% -58.70%
GlaxoSmithKline 1,790.20 3.60 0.20% 24.58%
Hikma Pharmaceutical 1,682.50 44.50 2.72% -34.74%
Johnson Matthey 1,874.00 55.50 3.05% -39.45%
Merck 171.70 3.85 2.29% 1.63%
Novartis 81.22 0.31 0.38% -4.41%
Philips 20.76 0.69 3.44% -48.41%
Roche Holding 323.35 4.35 1.36% -9.16%
Sanofi 97.90 0.78 0.80% 12.79%
Sika AG 218.50 5.90 2.78% -29.65%
Smith & Nephew PLC 1,165.00 35.00 3.10% -26.84%
Solvay 75.96 1.14 1.52% -29.37%
UCB 85.30 2.70 3.27% -4.16%
William Demant Holding 270.90 1.50 0.56% -28.26%

Indexes Price Day Year
CH20 10841 138.10 1.29% -10.30%

Lonza Group
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.